| Evaluation of Autologous Mesenchymal Stem Cell Transplantation (Effects and Side Effects) in Multiple Sclerosis (NCT01377870) | Royan Institute | 2011-12-01 |
| St. Jude Medical Percutaneous Mitral Valve Repair Study (NCT01500148) | Abbott Medical Devices | 2011-12-01 |
| A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands (NCT01351103) | Novartis Pharmaceuticals | 2011-12-01 |
| Study to Investigate the Safety, Pharmacokinetics, and Immunogenicity of Subcutaneous MCAF5352A in Healthy Volunteers (NCT01480310) | Genentech, Inc. | 2011-12-01 |
| A Comparison of the Safety and Comfort of AC-170 (NCT01495338) | Aciex Therapeutics, Inc. | 2011-12-01 |
| Phase-I Study of Radiolabeled DFH-12 (PulmoBind) for Molecular Imaging of the Pulmonary Circulation (NCT01539889) | Montreal Heart Institute | 2011-12-01 |
| Safety, Tolerability and Pharmacokinetics of Multiple Doses of AV-101 in Healthy Volunteers (NCT01483846) | VistaGen Therapeutics, Inc. | 2011-12-01 |
| Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors (NCT01421004) | Novartis Pharmaceuticals | 2011-12-01 |
| Safety Evaluation of Aminophylline and Methazolamide (NCT01587027) | Poudre Valley Health System | 2011-12-01 |
| Effects of the GLP-1 Exenatide on Satiety in Lean and Obese Women (NCT01501084) | University of California, Los Angeles | 2011-12-01 |
| Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T (NCT01543152) | Sangamo Therapeutics | 2011-12-01 |
| Phase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN) (NCT01465815) | OHSU Knight Cancer Institute | 2011-12-01 |
| Dose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has Returned (NCT01495663) | Cellectar Biosciences, Inc. | 2011-12-01 |
| LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic Cancer (NCT01485744) | Massachusetts General Hospital | 2011-12-01 |
| Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma (NCT01483820) | Giselle Sholler | 2011-12-01 |
| A Multiple Ascending Dose Study of CAT-1004 in Patients With Type 2 Diabetes (NCT01511900) | Catabasis Pharmaceuticals | 2011-12-01 |
| Phase I Study of 5-Fluorouracil in Children and Young Adults With Recurrent Ependymoma (NCT01498783) | St. Jude Children's Research Hospital | 2011-12-01 |
| Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma (NCT01339039) | Patrick Y. Wen, MD | 2011-12-01 |
| Impedance Measurements in Heart Failure Patients (NCT01509495) | Medtronic BRC | 2011-12-01 |
| Ph 1 Study of ADI PEG 20 in Pediatric Subjects Who Are Argininosuccinate Synthetase (ASS) Deficient (NCT01528384) | Polaris Group | 2011-12-01 |
| A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL (NCT01483690) | Therapeutic Advances in Childhood Leukemia Consortium | 2011-12-01 |
| Methadone-Dolutegravir (DTG - GSK1349572) Drug Interaction Study. (NCT01467518) | ViiV Healthcare | 2011-12-01 |
| Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of REGN668 Administered Subcutaneously to Healthy Volunteers (NCT01484600) | Regeneron Pharmaceuticals | 2011-12-01 |
| Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed/Refractory Multiple Myeloma (NCT01496118) | SCRI Development Innovations, LLC | 2011-12-01 |
| Stromal Vascular Fraction (SVF) for Treatment of Recto-vaginal Fistula (NCT01548092) | Instituto de Investigación Hospital Universitario La Paz | 2011-12-01 |
| A Phase 1 Clinical Trial to Investigate Pharmacokinetics and Drug Interaction of Crestor and Glucodown OR SR in Healthy Volunteers (NCT01526317) | Yuhan Corporation | 2011-12-01 |
| Evaluation of Safety and Efficacy of Remifentanil in Pediatric Population (NCT01477892) | Seoul National University Hospital | 2011-12-01 |
| Mobile Motivation for Health Promotion Among Adolescents (NCT02504658) | BodiMojo, Inc. | 2011-12-01 |
| Stromal Vascular Fraction (SVF) for Treatment of Enterocutaneous Fistula (HULPUTC) (NCT01584713) | Instituto de Investigación Hospital Universitario La Paz | 2011-12-01 |
| Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme (NCT01349660) | SCRI Development Innovations, LLC | 2011-12-01 |
| Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration (NCT01494805) | Lions Eye Institute, Perth, Western Australia | 2011-12-01 |
| Efficacy of RPh201 Applied Topically for the Treatment of Hard to Heal Chronic Ulcerated Wounds (NCT01429519) | Regenera Pharma Ltd | 2011-12-01 |
| Evaluation of the Safety and the Ability of a DNA Vaccine to Protect Against Dengue Disease (NCT01502358) | U.S. Army Medical Research and Development Command | 2011-12-01 |
| Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma (NCT01505608) | Giselle Sholler | 2011-12-01 |
| Safety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion of Treg Depleted T Cells for Adult WT1 Acute Myeloid Leukemia (NCT01513109) | Jules Bordet Institute | 2011-12-01 |
| Study of Inotuzumab Ozogamicin + Temsirolimus in Patients With Relapsed or Refractory CD22+ B-cell NHLymphoma (NCT01535989) | Cristiana Sessa | 2011-12-01 |
| Magnitude of Changes in 25 OH Vitamin D3 Levels After Vitamin D3 Supplementation (NCT01170507) | King Faisal Specialist Hospital & Research Center | 2011-12-01 |
| A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss (NCT01518920) | Biogen | 2011-12-01 |
| 1320 nm Nd:YAG Laser for Improving the Appearance of Onychomycosis (NCT01498393) | University of California, Irvine | 2011-12-01 |
| Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult Subjects (NCT01489345) | Ono Pharma USA Inc | 2011-12-01 |
| A Study To Investigate The Effect Of Food On The Pharmacokinetics Of PH-797804 (NCT01479647) | Pfizer | 2011-12-01 |
| A Study to Assess the Tolerability, Safety, Pharmacodynamics, and Pharmacokinetics of Ascending Single Doses (Including Food Interaction) and Ascending Multiple Doses of ACT-453859, and Multiple Doses of Setipiprant (ACT-129968) (NCT02381496) | Idorsia Pharmaceuticals Ltd. | 2011-12-01 |
| Open-Label Pilot Study of Lisdexamfetamine for Cocaine Dependence (NCT01486810) | New York State Psychiatric Institute | 2011-12-01 |
| First-in-Human Exploratory Single Ascending Dose of GLPG0974 (NCT01496937) | Lakefront Biotherapeutics NV | 2011-12-01 |
| Phase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer (NCT01416038) | ImmunoVaccine Technologies, Inc. (IMV Inc.) | 2011-12-01 |
| Pharmacokinetics of Sildenafil Following Administration of an Chewable Tablet of Sildenafil Relative to Viagra® Conventional Oral Tablet in Healthy Volunteers (NCT01514903) | Hanmi Pharmaceutical Company Limited | 2011-12-01 |
| Study to Compare the Pharmacokinetics Profiles of Four Racecadotril Products (NCT01476683) | McNeil AB | 2011-12-01 |
| Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of YHB1411-2 in Healthy Male Volunteers (NCT01525147) | Yuhan Corporation | 2011-12-01 |
| First in Man Study Investigating the Biodistribution, the Safety and Optimal Recommended Dose of a New Radiolabelled Monoclonal Antibody Targeting Frizzled Homolog 10 (NCT01469975) | Centre Leon Berard | 2011-12-01 |
| Comparison Study of Liquid and Lyophilized Formulations of Subcutaneous Tetrodotoxin (TTX) in Healthy Volunteers (NCT01527734) | Wex Pharmaceuticals Inc. | 2011-12-01 |
| Evaluation of the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of E2609 in Healthy Subjects (NCT01511783) | Eisai Inc. | 2011-12-01 |
| A Study of mTOR Inhibitor Everolimus (RAD001) in Association With Cisplatin and Radiotherapy for Locally Advanced Cervix Cancer (NCT01217177) | Novartis Pharmaceuticals | 2011-12-01 |
| A 2-week Trial Of PF-04991532 In Patients With Type 2 Diabetes (NCT01469065) | Pfizer | 2011-12-01 |
| Study Combining SAR245409 With Rituximab or Bendamustine Plus Rituximab in Patients With Indolent Lymphoma, Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia (NCT01410513) | Sanofi | 2011-12-01 |
| Behavioral Intervention for Low Income Depressed Smokers in Drug Treatment (NCT01372254) | University of Maryland, College Park | 2011-12-01 |
| Pasireotide, Everolimus and Selective Internal Radioembolization Therapy for Unresectable Hepatic Metastases (NCT01469572) | Emory University | 2011-12-01 |
| A Drug-Drug Interaction Study Between Danoprevir/Low-Dose Ritonavir and Cyclosporine in Healthy Volunteers (NCT01514968) | Hoffmann-La Roche | 2011-12-01 |
| Healthy Normal Volunteers Looking at Exposure and Effects of Multiple Doses of Technosphere® Insulin (TI) Using the Gen2C Inhaler (NCT01490762) | Mannkind Corporation | 2011-12-01 |
| Pharmacokinetic, Bioavailability, and Safety Study of COV155 Administered in Healthy Subjects Under Fed and Fasted Conditions (NCT02561650) | Mallinckrodt | 2011-12-01 |
| Phase 1/2 Sequentially Staged Safety Study in Healthy Subjects and Subjects With Mild Acne (NCT01490736) | Dermira, Inc. | 2011-12-01 |
| Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood (NCT01497184) | M.D. Anderson Cancer Center | 2011-12-01 |
| Emotional Effects of Methylphenidate and MDMA in Healthy Subjects (NCT01465685) | University Hospital, Basel, Switzerland | 2011-12-01 |
| Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine (NCT01506570) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-12-01 |
| Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer Subjects (NCT01517399) | Daiichi Sankyo | 2011-12-01 |
| Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors (NCT01518413) | HMeany | 2011-12-01 |
| Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function (NCT01478399) | PhaseBio Pharmaceuticals Inc. | 2011-12-01 |
| Safety and Immunogenicity Study of HIV-MAG Vaccine +/- IL-12 and Ad35-GRIN/ENV in HIV-uninfected Volunteers (NCT01496989) | International AIDS Vaccine Initiative | 2011-12-01 |
| Evaluation of Continuous Glucose Monitoring in Participants With Type 2 Diabetes Mellitus (MK-0000-258 AM2) (NCT01537120) | Merck Sharp & Dohme LLC | 2011-12-01 |
| Clinical Trial to Evaluate Safety and pK Profile of Metformin Glycinate in Healthy Volunteers (NCT01560481) | Laboratorios Silanes S.A. de C.V. | 2011-12-01 |
| Drug-Drug Interaction Study With Pravastatin and Cyclosporine (NCT01497483) | University of California, San Francisco | 2011-12-01 |
| Safety Study of the Angel™ Catheter in Subjects With Risk of Pulmonary Embolism (NCT01403090) | BiO2 Medical | 2011-12-01 |
| Ex Vivo Cultured Adult Allogenic MSCs in Ischemic Cerebral Stroke (NCT01091701) | Stempeutics Research Pvt Ltd | 2011-12-01 |
| Safety Study of AKN-028 in Patients With Acute Myelogenous Leukemia (NCT01573247) | Akinion Pharmaceuticals AB | 2011-12-01 |
| Donor Enhancement With Plerixafor Post Myeloablative Allogeneic Transplant (NCT01280955) | Mitchell Horwitz, MD | 2011-12-01 |
| Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA (NCT01550510) | Thomas Jefferson University | 2011-12-01 |
| Prediction of Cognitive Properties of New Drug Candidates for Neurodegenerative Diseases in Early Clinical Development (NCT01487395) | University Hospital, Lille | 2011-12-01 |
| Panitumumab and Bortezomib for Patients With Advanced Colorectal Cancer (NCT01504477) | Georgetown University | 2011-12-01 |
| PD-0332991, 5-FU, and Oxaliplatin for Advanced Solid Tumor Malignancies (NCT01522989) | Georgetown University | 2011-12-01 |
| Pharmacokinetics of Certoparin in Subjects With Renal Insufficiency and Healthy Subjects (NCT01660295) | Novartis Pharmaceuticals | 2011-12-01 |
| Implementation of a Personalized Medicine (Pharmacogenomics) Service in a Community Pharmacy (NCT01495845) | University of North Carolina, Chapel Hill | 2011-12-01 |
| Assessment of Exposure of BI 409306 in Cerebrospinal Fluid (CSF) Relative to Plasma as Well as to Evaluation of the Effect of Different Doses of BI 409306 on the cGMP (Cyclic Guanosine Monophosphate) Levels in CSF in Healthy Male Volunteers (NCT01493570) | Boehringer Ingelheim | 2011-12-01 |
| STIT-2: Evaluation of Safety and Efficacy of Short-time TNI® Treatment in Patients With COPD and Hypercapnia (NCT01693146) | Medical University Innsbruck | 2011-12-01 |
| VXM01 Phase I Dose Escalation Study in Patients With Locally Advanced, Inoperable and Stage IV Pancreatic Cancer (NCT01486329) | Vaximm GmbH | 2011-12-01 |
| Tele-IPT for HIV-Infected Rural Persons (NCT02299453) | University of Georgia | 2011-12-01 |
| Phase 2a, Exploratory Study to Evaluate the Safety, Efficacy, Tolerability and Pharmacokinetics of XPF-002 in Patients With Primary/Inherited Erythromelalgia (NCT01486446) | Xenon Pharmaceuticals Inc. | 2011-12-01 |
| Drug Interaction Study of Isavuconazole and Tacrolimus (NCT01535547) | Astellas Pharma Inc | 2011-12-01 |
| Evaluating the Immune Response to a rAd5 HIV Vaccine Administered in Three Different Ways in Healthy, HIV-Uninfected Adults (NCT01479296) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-12-01 |
| Human Neural Stem Cell Transplantation in Amyotrophic Lateral Sclerosis (ALS) (NCT01640067) | Azienda Ospedaliera Santa Maria, Terni, Italy | 2011-12-01 |
| A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral ZYGK1 in Healthy Volunteers (NCT01472809) | Zydus Lifesciences Limited | 2011-12-01 |
| Polarized Reflectance Spectroscopy for Oral Lesions (NCT01604759) | British Columbia Cancer Agency | 2011-12-01 |
| Malaria Challenge in Healthy Volunteers (NCT01500980) | Seattle Children's Hospital | 2011-12-01 |
| AZD5069 Neutrophil Function Study (NCT01480739) | AstraZeneca | 2011-12-01 |
| Traumatic Brain Injury Peripheral Nerve Study (NCT01588691) | Abbott Medical Devices | 2011-12-01 |
| Single Port Laparoscopic Colectomy (NCT01320267) | University of British Columbia | 2011-12-01 |
| Chikungunya Virus Vaccine Trial in Healthy Adults (NCT01489358) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-12-01 |
| A Pharmacokinetic and Safety Study of Osmotic Release Oral System (OROS) Hydromorphone in Non-Opioid Tolerant Chinese Participants With Cancer (NCT01824524) | Xian-Janssen Pharmaceutical Ltd. | 2011-12-01 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-451840 in Healthy Subjects (Part A) (NCT02186002) | Idorsia Pharmaceuticals Ltd. | 2011-12-01 |
| A Study of RO5028442 in Adult Male High-Functioning Autistic Patients (NCT01474278) | Hoffmann-La Roche | 2011-12-01 |
| Study to Evaluate the Pharmacodynamics and Safety of HGS1025 in Patients With Ulcerative Colitis (NCT01434576) | Human Genome Sciences Inc. | 2011-12-01 |
| Pharmacokinetics and Safety Study of BI 695501 in Healthy Subjects (NCT01505491) | Boehringer Ingelheim | 2011-12-01 |